The development of an electrochemical immunosensor for BNP detection offers a potentially faster and convenient tool for heart failure diagnosis.
A study of B-type natriuretic peptide (BNP) antigen as a good prognostic marker for patients with heart failure antigen detection employing an electrochemical immunosensor is described here. Monoclonal anti-BNP capture antibody was immobilized on streptavidin-modified SPCEs to increase the sensitivity of the assay. An anti-BNP detection antibody conjugated with horseradish peroxidase enzyme (HRP) and 3,3,5,5’-tetramethybezidine dihydrochloride (TMB) was used as a substrate, in connection with voltammetric technique was achieve by measuring the peak current. Incorporation of a streptavidin/biotin system resulted in a well-oriented antibody immobilization of the capture antibody and consequently enhanced the sensitivity of the assay. Several optimizations were performed to reduce background signals; the optimal concentration of anti-BNP detection antibody needed, the time of SPCEs were first blocked with glycine, incubated with various concentrations of BNP and HRP-conjugated anti-BNP detection antibody (0 to 100.0 ng/mL), followed by electrochemical measurement were investigated,. In conclusion, this immunosensor greatly shortened and convenient for detection of heart failure diagnosis in real serum samples.
No takes yet. Share an insight, caveat, or question.
Hartati et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: